Warts, Herpes Simplex, And Ot... Health Article

Advertisement
Marketplace
Licensed from
Page: < Back 1 2 3 4 5 6 7 Next >

Herpes Simplex

Genital herpes simplex virus (HSV) infections are discussed in.

HSV infections are caused by two different virus types (HSV-1 and HSV-2), which can be distinguished by laboratory and office tests. HSV-1 is generally associated with oral infections, and HSV-2 is associated with genital infections. HSV-1 genital infections and HSV-2 oral infections are becoming more common, possibly as a result of oral-genital sexual contact. Both types seem to produce identical patterns of infection. Many infections are asymptomatic, and evidence of previous infection can be detected only by an elevated IgG antibody titer. HSV infections have two phases: the primary infection, after which the virus becomes established in a nerve ganglion; and the secondary phase, characterized by recurrent disease at the same site. The rate of recurrence varies with virus type and anatomic site. Genital recurrences are nearly 6 times more frequent than oral-labial recurrences; genital HSV-2 infections recur more often than genital HSV-1 infections; and oral-labial HSV-1 infections recur more often than oral HSV-2 infections. 27 Infections can occur anywhere on the skin. Infection in one area does not protect the patient from subsequent infection at a different site. Lesions are intraepidermal and usually heal without scarring.

Primary infection

Many primary infections are asymptomatic and can be detected only by an elevated IgG antibody titer. Like most virus infections, the severity of disease increases with age. The virus may be spread via respiratory droplets, direct contact with an active lesion, or contact with virus-containing fluid such as saliva or cervical secretions in patients with no evidence of active disease. Symptoms occur from 3 to 7 or more days after contact. Tenderness, pain, mild paresthesias, or burning occurs before the onset of lesions at the site of inoculation. Localized pain, tender lymphadenopathy, headache, generalized aching, and fever are characteristic prodromal symptoms. Some patients have no prodromal symptoms.

LESIONS.

Grouped vesicles on an erythematous base appear and subsequently umbilicate (Figure 12-26). The vesicles in primary herpes simplex (Figures 12-27 and 12-28) are more numerous and scattered than those in the recurrent infection (Figures 12-29 and 12-30). The vesicles of herpes simplex are uniform in size in contrast to the vesicles seen in herpes zoster, which vary in size. Mucous membrane lesions accumulate exudate, whereas skin lesions form a crust. Lesions last for 2 to 4 weeks unless secondarily infected and heal without scarring.

The virus replicates at the site of primary infection. Virons are then transported by neurons via retrograde axonal flow to the dorsal root ganglia, and latency is established in the ganglion.

Recurrent infection

Local skin trauma (e.g., ultraviolet light exposure, chapping, abrasion) or systemic changes (e.g., menses, fatigue, fever) reactivate the virus, which then travels down the peripheral nerves to the site of initial infection and causes the characteristic focal, recurrent infection. Recurrent infection is not inevitable. Many individuals have a rise in antibody titer and never experience recurrence. The prodromal symptoms of itching or burning, lasting 2 to 24 hours, resemble those of the primary infection. Within 12 hours, a group of lesions evolves rapidly from an erythematous base to form papules and then vesicles. The dome-shaped, tense vesicles rapidly umbilicate. In 2 to 4 days, they rupture, forming aphthaelike erosions in the mouth and vaginal area or erosions covered by crusts on the lips and skin. Crusts are shed in approximately 8 days to reveal a pink, reepithelialized surface. In contrast to the primary infection, systemic symptoms and lymphadenopathy are rare unless there is secondary infection.

The frequency of recurrence varies with anatomic site and virus type. 27 HSV-1 oral infections recur more often than genital HSV-1 infections; HSV-2 genital infections recur 6 times more frequently than HSV-1 genital infections; and the frequency of recurrence is lowest for oral-labial HSV-2 infections.

LABORATORY DIAGNOSIS.

The laboratory diagnosis of herpes simplex is covered in, which discusses sexually transmitted viral infections.

TREATMENT.

A number of measures can be taken to relieve discomfort and promote healing; these are described in the following sections. The appropriate use of topical, oral, and intravenous antiviral agents is outlined (Table 12-2 and Box 12-1). Oral drugs decrease the duration of viral excretion, new lesion formation, and vesicles and promote rapid healing. The subsequent recurrence rate is not influenced by acyclovir. Acyclovir-resistant HSV infections are becoming a problem in patients with AIDS. L-Lysine is not effective.

Oral-labial herpes simplex
Primary infection

Transmission is dependent on intimate, personal contact with someone excreting HSV. Gingivostomatitis and pharyngitis are the most frequent manifestations of first-episode HSV-1 infection. Infection occurs most commonly in children between ages 1 and 5 years. The incubation period is 3 to 12 days. Although most cases are mild, some are severe. Sore throat and fever may precede the onset of painful vesicles occurring anywhere in the oral cavity or on the face (see Figures 12-27 and 12-28). The vesicles rapidly coalesce and erode with a white, then yellow, superficial, purulent exudate. Children are unable to swallow liquids because of the edema, ulcerations, and pain. Tender cervical lymphadenopathy develops. Fever subsides in 3 to 5 days, and oral pain and erosions are usually gone in 2 weeks; in severe cases, they may last for 3 weeks.

Recurrent infection

Recurrences average two or three each year but may occur as often as 12 times a year. Oral HSV-1 infections recur more often than oral HSV-2 infections. 27 Recurrent oral herpes simplex can appear as a localized cluster of small ulcers in the oral cavity, but the most common manifestation consists of eruptions on the vermilion border of the lip (recurrent herpes labialis) (Figures 12-29 , 12-31 , 12-33 , and 12-34). Fever (fever blisters), upper respiratory infections (cold sores), and exposure to ultraviolet light (Figure 12-31), among other things, may precede the onset. The course of the disease in the oral-labial area is the same as it is in other areas. Immunosuppressed patients are at greater risk of developing lesions on the lips, in the oral cavity, and on surrounding skin (Figure 12-32). Lesions may also appear on the upper lip and chin (Figure 12-35). The recurrence rate and long-term natural history are not well defined. Many people experience a decrease in the frequency of recurrences, but others experience an increase. A history of recurrent herpes labialis is present in 38% of college students. The prevalence of asymptomatic excretion of HSV following recurrence varies from 1% to 5% in adults.

TREATMENT.

A number of treatment modalities have been used for herpes on the vermilion border. Oral acyclovir, famciclovir, and valacyclovir can be used to treat the primary infection and episodic recurrences and for suppression (see Table 12-2 and Box 12-1). Oral antiviral drugs have a modest clinical benefit only if initiated very early after recurrence. They may be of value in patients whose recurrences are associated with protracted clinical illness. Oral antiviral drugs can alter the severity of sun-induced reactivation. Short-term prophylactic treatment may help patients who anticipate high-risk activity (e.g., intense sunlight exposure). Intermittent administration does not alter the frequency of subsequent recurrences.

COMBINATION TREATMENT.

Corticosteroids in combination with an oral antiviral agent may be beneficial for episodic treatment of herpes labialis. Famciclovir (500 mg tid for 5 days) and topical fluocinonide (0.05% tid for 5 days) significantly reduced lesion size and pain. 28

TOPICAL TREATMENT.

Topical treatments include penciclovir cream (Denavir), n -docosanol cream (Abreva), and acyclovir cream. Abreva is an over-the-counter drug. The cream is applied frequently (e.g., every 2 hours while awake) at the first sign of prodromal symptoms or erythema. These creams may shorten an episode of herpes labialis by a few hours or a day and may not be worth the high cost. Many patients believe that these creams are effective and prefer them to oral medication.

The lips should be protected from sun exposure with an opaque cream such as zinc oxide or with sun-blocking agents incorporated into a lip balm (Chap Stick). A cool water or Burrow's solution compress decreases erythema and debrides crusts to promote healing.

Lubricating creams may be applied if the lips become too dry.

Cutaneous herpes simplex

Herpes simplex may appear on any skin surface (Figures 12-36 and 12-37). It is important to identify all of the characteristic features when attempting to differentiate cutaneous herpes from other vesicular eruptions.

HERPETIC WHITLOW.

Herpes simplex of the fingertip (herpetic whitlow) (Figure 12-38) can resemble a group of warts or a bacterial infection. Health care professionals who had frequent contact with oral secretions used to be the most commonly affected group; the incidence has decreased, probably as a result of heightened awareness of the condition and stricter infection-control precautions. Herpetic whitlow is most often reported in pediatric patients with gingivostomatitis and in women with genital herpes. 29

HERPES GLADIATORUM.

Cutaneous herpes in athletes involved in contact sports is transmitted via direct skin-to-skin contact. This is a recognized health risk for wrestlers. 30 Prompt identification and exclusion of wrestlers with skin lesions may reduce transmission.

HERPES SIMPLEX OF THE BUTTOCK.

Herpes simplex of the buttock area is much more common in women (Figures 12-39 and 12-40). The cause of infection in this area has not been identified.

HERPES SIMPLEX OF THE TRUNK.

Herpes simplex of the lumbosacral region or trunk may be very difficult to differentiate from herpes zoster; the diagnosis becomes apparent only at the time of recurrence.

TREATMENT.

Oral antiviral drugs are useful for suppressive therapy, particularly for recurrent fingertip and buttock infections. 31

Eczema herpeticum

Eczema herpeticum (Kaposi's varicelliform eruption) is the association of two common conditions: atopic dermatitis and HSV infection. Certain atopic infants and adults may develop the rapid onset of diffuse cutaneous herpes simplex. The severity of infection ranges from mild and transient to fatal. The disease is most common in areas of active or recently healed atopic dermatitis, particularly the face, but normal skin can be involved. The disease in most cases is a primary HSV infection. In one third of the patients in a particular study, there was a history of herpes labialis in a parent in the previous week. 32 Recurrences are uncommon and usually limited. Approximately 10 days after exposure, numerous vesicles develop, become pustular, and umbilicate markedly (Figure 12-41). Secondary staphylococcal infection commonly occurs. New crops of vesicles may appear during the following weeks. The most intense viral dissemination is located in the areas of dermatitis, but normal appearing skin may ultimately be involved. High fever and adenopathy occur 2 to 3 days after the onset of vesiculation. The fever subsides in 4 to 5 days in uncomplicated cases, and the lesions evolve in the typical manner (Figure 12-42). Viremia with infection of internal organs can be fatal. Recurrent disease is milder and usually without constitutional symptoms.

TREATMENT.

Eczema herpeticum of the young infant is a medical emergency; early treatment with acyclovir can be life saving. 33,34 Eczema herpeticum is managed with cool, wet compresses, similar to the management of diffuse genital herpes simplex. Oral dosages of acyclovir 25 to 30 mg/kg/day have been effective. 35 Infants were successfully treated with intravenous acyclovir, 1500 mg/m 2 /day administered over a 1-hour period tid. 36,37 Oral antistaphylococcal antibiotics are an important part of treatment. Minor relapses do not require a second course of acyclovir. Adults respond to the standard intravenous acyclovir dosage of 250 mg tid. Oral antiviral drugs (see Table 12-2) are expected to be equally effective.

Page: < Back 1 2 3 4 5 6 7 Next >
Clinical Dermatology

© 2005 ELSEVIER Inc. All Rights Reserved
 
Related Learning
Centers
Advertisement
Back to Top